Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Multiple Sclerosis

  Free Subscription


Articles published in Int J Neurosci

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    August 2018
  1. JAHANBANI-ARDAKANI H, Alsahebfosoul F, Moshfeghi SR, Mahaki B, et al
    Serum level of Interleukin 12 in patients with multiple sclerosis.
    Int J Neurosci. 2018 Aug 8:1-7. doi: 10.1080/00207454.2018.1504782.
    PubMed     Text format    


    May 2018
  2. MARKOVA J, Essner U, Akmaz B, Marinelli M, et al
    Sativex(R) as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial.
    Int J Neurosci. 2018 May 24:1-26. doi: 10.1080/00207454.2018.1481066.
    PubMed     Text format     Abstract available


    January 2018
  3. FAHMY EM, Elfayoumy NM, Abdelalim AM, Sharaf SA, et al
    Relation of serum levels of homocysteine, vitamin B12 and folate to cognitive functions in multiple sclerosis patients.
    Int J Neurosci. 2018 Jan 31:1-23. doi: 10.1080/00207454.2018.1435538.
    PubMed     Text format     Abstract available


  4. LI LM, Guo HY, Zhao N, Zhang LJ, et al
    Comparison of olfactory function between neuromyelitis optica and multiple sclerosis.
    Int J Neurosci. 2018 Jan 3:1-21. doi: 10.1080/00207454.2018.1424152.
    PubMed     Text format     Abstract available


    October 2017
  5. ABDOLLAH ZADEH R, Moradi Pordanjani P, Rahmani F, Mashayekhi F, et al
    Association of VDR gene polymorphisms with risk of Relapsing-remitting multiple sclerosis in an Iranian Kurdish population.
    Int J Neurosci. 2017 Oct 26:1-17. doi: 10.1080/00207454.2017.1398158.
    PubMed     Text format     Abstract available


    January 2017
  6. KIM G, Chu R, Yousuf F, Tauhid S, et al
    Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis.
    Int J Neurosci. 2017 Jan 19:1-34. doi: 10.1080/00207454.2017.1283313.
    PubMed     Text format     Abstract available


    December 2016
  7. DAHDALEH M, Alroughani R, Aljumah M, AlTahan A, et al
    Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?
    Int J Neurosci. 2016 Dec 28:1-16. doi: 10.1080/00207454.2016.1277424.
    PubMed     Text format     Abstract available


  8. LASEK-BAL A, Bartoszek K, Steposz A, Puz P, et al
    Efficacy and safety of mitoxantrone use in primary and secondary progressive multiple sclerosis - study site experience based on the therapy of 104 patients.
    Int J Neurosci. 2016.
    PubMed     Text format     Abstract available


    November 2016
  9. GAO C, Wu L, Chen X, Long Y, et al
    Hypothalamic abnormality in patients with inflammatory demyelinating disorders.
    Int J Neurosci. 2016;126:1036-43.
    PubMed     Text format     Abstract available


    September 2016
  10. JAMROZ-WISNIEWSKA A, Beltowski J, Bartosik-Psujek H, Wojcicka G, et al
    Processes of plasma protein N-homocysteinylation in multiple sclerosis.
    Int J Neurosci. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: